ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome

ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome

Background: It is unclear why primary nephrotic syndrome (PNS) patients often have dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an important regulator of lipid metabolism. In this study, we explored how ANGPTL3 impacts dyslipidemia during PNS development. Met...

Full description

Bibliographic Details
Main Authors: Cui, W. (Author), Gao, X. (Author), Li, G. (Author), Li, Y. (Author), Liu, M. (Author), Liu, S. (Author), Suo, Y. (Author), Wang, J. (Author), Zhong, F. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
angiopoietin related protein
Angiopoietin-Like Protein 3
Angiopoietin-like Proteins
ANGPTL3
ANGPTL3 protein, human
Angptl3 protein, mouse
animal
Animals
dyslipidemia
Dyslipidemias
genetics
human
Humans
hyperlipidemia
Hyperlipidemia
Hyperlipidemias
lipopolysaccharide
Lipopolysaccharides
metabolism
Mice
mouse
nephrotic syndrome
Nephrotic syndrome
Nephrotic Syndrome
proteinuria
Proteinuria
triacylglycerol
Triglycerides
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items